Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

EpiPen Television Ad Settlement – Massachusetts

Pfizer and Mylan Specialty, L.P. agreed to pay Massachusetts a total of $625,000 to settle allegations that a television advertisement for the EpiPen and EpiPen Jr. self-injectors was misleading and overstated the effectiveness of the product. The EpiPen device, which allows for self-injection of the steroid epinephrine for emergency treatment of allergic reactions, is made by Pfizer and marketed by Mylan. Massachusetts alleged that the television ad, which aired in April 2012, “put consumers at risk by giving an overall misleading impression that the product alone removes the need to take precautionary measures.” The television ad triggered a warning letter from the U.S. Food and Drug Administration in May 2012 and was pulled after parents and advocacy groups complained. Pfizer will pay Massachusetts $375,000. In December 2012, Pfizer paid Oregon $1 million over the same ad campaign (see Pfizer instance, “EpiPen Television Ad Settlement – Oregon”).

Misconduct Type
Consumer Affairs
Enforcement Agency
State/Local
Contracting Party
None
Court Type
Civil
Disposition
Settlement
Date of Settlement Announcement
11/7/2013
Contractors Involved Penalty
Total
Pfizer, Inc. $375,000
Further Information Released
Massachusetts AG Press Release 11/7/2013
FDA Warning Letter 5/24/2012
Epi-Pen TV Ad Layout 4/1/2012

See also:

Federal Contractor Misconduct Database